GE gets clearance for NT workstations
GE Medical Systems has received Food and Drug Administration 510(k) clearance for its Platinum line of Windows NT-based diagnostic and clinical review workstations. The workstations, which will also employ Java technology, are scheduled for a
GE Medical Systems has received Food and Drug Administration 510(k) clearance for its Platinum line of Windows NT-based diagnostic and clinical review workstations. The workstations, which will also employ Java technology, are scheduled for a fourth-quarter commercial release, according to the Milwaukee company.
The regulatory approval marks an important milestone for GE in its quest for PACS market dominance. With customer interest centering on systems based on the Microsoft platform, many market watchers consider a lack of an NT-based offering a liability. GE's PACS is currently based on the Macintosh platform.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
